C-Reactive Protein and Endovascular Treatment of Lower Limb Peripheral Artery Disease

C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization

(2014) Patrick A. Stone et al.   JOURNAL OF VASCULAR SURGERY

Inflammatory Burden Predicts Long-Term Outcomes in Endovascular Therapy in Peripheral Arterial Disease

(2013) Silvia Bleda et al.   ANNALS OF VASCULAR SURGERY

Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease

(2012) Hideki Ishii et al.   ATHEROSCLEROSIS

Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents

(2010) Dong-Hyun Choi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received

(2010) Andrew W. Bradbury et al.   JOURNAL OF VASCULAR SURGERY

Stenting de l’artère fémorale superficielle et C-Reactive Protein ultrasensible (CRPus) : étude multicentrique SAFE de 255 patients

(2010) Jean-Paul Beregi et al.   PRESSE MEDICALE